-
Patent Agency Ranking
公开(公告)号：US20210130293A1
公开(公告)日：2021-05-06
申请号：US16654141
申请日：2019-10-16
Applicant: AbbVie Inc.
Inventor： Maria A. Argiriadi , Eric C. Breinlinger , Kevin P. Cusack , Adrian D. Hobson , Dominique Potin , Martine Barth , Jerome Amaudrut , Olivia Poupardin , Laurent Mounier , Michael E. Kort
IPC: C07D209/08 , C07D401/10 , C07D403/10 , C07D401/14 , C07D405/12 , C07D401/06 , C07D491/107 , C07D405/14 , C07D235/06 , C07D471/04 , C07D487/04 , C07D231/56 , C07D235/16 , C07D405/10 , C07D491/10 , C07D209/14 , C07D209/18
Abstract: The invention provides compounds of Formula (I) pharmaceutically acceptable salts, thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological conditions.
-
公开(公告)号：US20230066771A1
公开(公告)日：2023-03-02
申请号：US17443264
申请日：2021-07-23
Applicant: AbbVie Inc.
Inventor： Maria A. Argiriadi , Eric C. Breinlinger , Kevin P. Cusack , Adrian D. Hobson , Dominique Potin , Martine Barth , Jerome Amaudrut , Olivia Poupardin , Laurent Mounier , Michael E. Kort
IPC: C07D209/08 , C07D401/10 , C07D403/10 , C07D401/14 , C07D405/12 , C07D401/06 , C07D491/107 , C07D405/14 , C07D235/06 , C07D471/04 , C07D487/04 , C07D231/56 , C07D235/16 , C07D405/10 , C07D491/10 , C07D209/14 , C07D209/18
Abstract: The invention provides compounds of Formula (I) pharmaceutically acceptable salts, thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological conditions.
-
公开(公告)号：US10106501B2
公开(公告)日：2018-10-23
申请号：US15176309
申请日：2016-06-08
Applicant: AbbVie Inc.
Inventor： Maria A. Argiriadi , Eric C. Breinlinger , Kevin P. Cusack , Adrian D. Hobson , Dominique Potin , Martine Barth , Jerome Amaudrut , Olivia Poupardin , Laurent Mounier , Michael E. Kort
IPC: C07D209/08 , C07D401/10 , C07D403/10 , C07D401/14 , C07D405/12 , C07D401/06 , C07D491/107 , C07D405/14 , C07D235/06 , C07D471/04 , C07D487/04 , C07D231/56 , C07D235/16 , C07D405/10 , C07D491/10 , C07D209/14 , C07D209/18
Abstract: The invention provides compounds of Formula (I) pharmaceutically acceptable salts, thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological conditions.
-
公开(公告)号：US20190055196A1
公开(公告)日：2019-02-21
申请号：US16108230
申请日：2018-08-22
Applicant: AbbVie Inc.
Inventor： Maria A. Argiriadi , Eric C. Breinlinger , Kevin P. Cusack , Adrian D. Hobson , Dominique Potin , Martine Barth , Jerome Amaudrut , Olivia Poupardin , Laurent Mounier , Michael E. Kort
IPC: C07D209/08 , C07D231/56 , C07D235/16 , C07D471/04 , C07D235/06 , C07D405/14 , C07D491/107 , C07D401/06 , C07D405/12 , C07D401/14 , C07D403/10 , C07D401/10 , C07D209/18 , C07D209/14 , C07D491/10 , C07D405/10 , C07D487/04
Abstract: The invention provides compounds of Formula (I) pharmaceutically acceptable salts, thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological conditions.
-
公开(公告)号：US20160362370A1
公开(公告)日：2016-12-15
申请号：US15176309
申请日：2016-06-08
Applicant: AbbVie Inc.
Inventor： Maria A. Argiriadi , Eric C. Breinlinger , Kevin P. Cusack , Adrian D. Hobson , Dominique Potin , Martine Barth , Jerome Amaudrut , Olivia Poupardin , Laurent Mounier , Michael E. Kort
IPC: C07D209/08 , C07D403/10 , C07D401/14 , C07D405/12 , C07D231/56 , C07D491/107 , C07D405/14 , C07D235/06 , C07D471/04 , C07D487/04 , C07D401/10 , C07D401/06
CPC classification number: C07D209/08 , C07D209/14 , C07D209/18 , C07D231/56 , C07D235/06 , C07D235/16 , C07D401/06 , C07D401/10 , C07D401/14 , C07D403/10 , C07D405/10 , C07D405/12 , C07D405/14 , C07D471/04 , C07D487/04 , C07D491/10 , C07D491/107
Abstract: The invention provides compounds of Formula (I) pharmaceutically acceptable salts, thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological conditions.
Abstract translation: 其药学上可接受的盐，其中所述变量在本文中定义。 本发明的化合物可用于治疗免疫学病症。
-
-
-
-
Search Results
5
records
(took 0.021 seconds)
